chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered with expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032N20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Crosslinked with MOD21-141427, MOD21-141586, MOD21-141640, MOD21-141641, MOD21-141642, MOD21-141643, MOD21-141644, MOD21-141645, MOD21-141646. There were 9 patients instead of 10 as initially reported.  This case is for the 9th patient. Concomitant medications was not provided by the reporter Treatment information was not provided   This case was linked to MOD-2021-314567, MOD-2021-314573, MOD-2021-314570, MOD-2021-314793 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2021: Possible NNI.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Got COVID after being vaccinated with the Moderna COVID19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID after being vaccinated with the Moderna COVID19 vaccine ) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got COVID after being vaccinated with the Moderna COVID19 vaccine ). At the time of the report, COVID-19 (Got COVID after being vaccinated with the Moderna COVID19 vaccine ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication use was reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Headache
Clinical narrative: Got COVID after vaccination; shortness of breath; headaches; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID after vaccination), DYSPNOEA (shortness of breath) and HEADACHE (headaches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got COVID after vaccination), DYSPNOEA (shortness of breath) and HEADACHE (headaches). At the time of the report, COVID-19 (Got COVID after vaccination), DYSPNOEA (shortness of breath) and HEADACHE (headaches) outcome was unknown.            Concomitant product use was not provided by the reporter.   No treatment information was provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Illness
Clinical narrative: Sick after second Shot; Chills after second Shot; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick after second Shot) and CHILLS (Chills after second Shot) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced ILLNESS (Sick after second Shot) and CHILLS (Chills after second Shot). On 19-Feb-2021, ILLNESS (Sick after second Shot) and CHILLS (Chills after second Shot) had resolved.            No concomitant medication was provided. No treatment medication was provided. Patient was Out of it, after second Shot.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: Had numbness and tingling in her face, neck and cheeks; Had numbness and tingling in her face, neck and cheeks; Had achiness for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Had numbness and tingling in her face, neck and cheeks), PARAESTHESIA (Had numbness and tingling in her face, neck and cheeks) and PAIN (Had achiness for a couple of days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Had numbness and tingling in her face, neck and cheeks), PARAESTHESIA (Had numbness and tingling in her face, neck and cheeks) and PAIN (Had achiness for a couple of days). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (Had numbness and tingling in her face, neck and cheeks) and PARAESTHESIA (Had numbness and tingling in her face, neck and cheeks) had resolved and PAIN (Had achiness for a couple of days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.   This case was linked to MOD-2021-314631 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Experienced hives in arms, hands and legs; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Experienced hives in arms, hands and legs) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety and ADHD. Concomitant products included LISDEXAMFETAMINE MESILATE (VYVANSE) for ADHD, DESVENLAFAXINE SUCCINATE MONOHYDRATE (PRISTIQ) for Anxiety, LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.    On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Aug-2021, the patient experienced URTICARIA (Experienced hives in arms, hands and legs). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 01-Aug-2021 for Hives, at a dose of 1 dosage form. On 01-Aug-2021, URTICARIA (Experienced hives in arms, hands and legs) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Feeling abnormal
Clinical narrative: Feeling low; Dizzy; Weak; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling low), DIZZINESS (Dizzy) and ASTHENIA (Weak) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 642620A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Sep-2021, the patient experienced FEELING ABNORMAL (Feeling low), DIZZINESS (Dizzy) and ASTHENIA (Weak). On 09-Sep-2021, FEELING ABNORMAL (Feeling low), DIZZINESS (Dizzy) and ASTHENIA (Weak) had resolved.            Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Limb discomfort, Mobility decreased
Clinical narrative: 4-5 days later, I noticed my motor skills are slow/getting up from bed is difficult; Walking difficulty; Leg discomfort; She is experiencing pain in her joints, knees, and elbows; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (4-5 days later, I noticed my motor skills are slow/getting up from bed is difficult), GAIT DISTURBANCE (Walking difficulty), LIMB DISCOMFORT (Leg discomfort) and ARTHRALGIA (She is experiencing pain in her joints, knees, and elbows) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE, OLMESARTAN MEDOXOMIL (OLMESARTAN HCTZ), LEVOTHYROXINE, MULTIVITAMIN [VITAMINS NOS], CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 24-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Aug-2021, the patient experienced MOBILITY DECREASED (4-5 days later, I noticed my motor skills are slow/getting up from bed is difficult), GAIT DISTURBANCE (Walking difficulty), LIMB DISCOMFORT (Leg discomfort) and ARTHRALGIA (She is experiencing pain in her joints, knees, and elbows). At the time of the report, MOBILITY DECREASED (4-5 days later, I noticed my motor skills are slow/getting up from bed is difficult), GAIT DISTURBANCE (Walking difficulty), LIMB DISCOMFORT (Leg discomfort) and ARTHRALGIA (She is experiencing pain in her joints, knees, and elbows) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment was not specified.   This case was linked to MOD-2021-275275 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: severe adverse reactions; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (severe adverse reactions) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (severe adverse reactions). At the time of the report, ADVERSE REACTION (severe adverse reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided. No treatment information was reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia
Clinical narrative: Fever (102,1 °F); Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever (102,1 °F)), CHILLS (Chills) and FATIGUE (Fatigue) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F71A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for Hypertension.    On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, the patient experienced PYREXIA (Fever (102,1 °F)), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, PYREXIA (Fever (102,1 °F)), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.2 (High) 101,2 °F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patient received a vaccine that had Expiration date Mar 06, 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment information was reported.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chest pain, Chills, Heart rate, Hypotension
Clinical narrative: My blood pressure was 101/52/ low blood pressure; CHEST PAIN; NAUSEA; CHILLS; MYALGIA; I received the dose at 4pm, I wasn't feeling well when I went to bed.; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (I received the dose at 4pm, I wasn't feeling well when I went to bed.), HYPOTENSION (My blood pressure was 101/52/ low blood pressure), CHEST PAIN (CHEST PAIN), NAUSEA (NAUSEA) and CHILLS (CHILLS) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A and 939902) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided by the reporter.  Concomitant products included MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Sep-2021 at 4:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (I received the dose at 4pm, I wasn't feeling well when I went to bed.). On 09-Sep-2021, the patient experienced HYPOTENSION (My blood pressure was 101/52/ low blood pressure), CHEST PAIN (CHEST PAIN), NAUSEA (NAUSEA), CHILLS (CHILLS) and MYALGIA (MYALGIA). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (I received the dose at 4pm, I wasn't feeling well when I went to bed.), HYPOTENSION (My blood pressure was 101/52/ low blood pressure), CHEST PAIN (CHEST PAIN), NAUSEA (NAUSEA), CHILLS (CHILLS) and MYALGIA (MYALGIA) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Sep-2021, Blood pressure measurement: 101/52 (Low) LOW. On 09-Sep-2021, Heart rate: 116 (High) HIGH.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea
Clinical narrative: My blood pressure was 101/52/ low blood pressure; CHEST PAIN; NAUSEA; CHILLS; MYALGIA; I received the dose at 4pm, I wasn't feeling well when I went to bed.; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (I received the dose at 4pm, I wasn't feeling well when I went to bed.), HYPOTENSION (My blood pressure was 101/52/ low blood pressure), CHEST PAIN (CHEST PAIN), NAUSEA (NAUSEA) and CHILLS (CHILLS) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A and 939902) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided by the reporter.  Concomitant products included MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Sep-2021 at 4:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (I received the dose at 4pm, I wasn't feeling well when I went to bed.). On 09-Sep-2021, the patient experienced HYPOTENSION (My blood pressure was 101/52/ low blood pressure), CHEST PAIN (CHEST PAIN), NAUSEA (NAUSEA), CHILLS (CHILLS) and MYALGIA (MYALGIA). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (I received the dose at 4pm, I wasn't feeling well when I went to bed.), HYPOTENSION (My blood pressure was 101/52/ low blood pressure), CHEST PAIN (CHEST PAIN), NAUSEA (NAUSEA), CHILLS (CHILLS) and MYALGIA (MYALGIA) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Sep-2021, Blood pressure measurement: 101/52 (Low) LOW. On 09-Sep-2021, Heart rate: 116 (High) HIGH.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Pyrexia
Clinical narrative: stomach is queasy; 100.4 fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach is queasy), PYREXIA (100.4 fever) and CHILLS (chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Sep-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach is queasy), PYREXIA (100.4 fever) and CHILLS (chills). At the time of the report, ABDOMINAL DISCOMFORT (stomach is queasy), PYREXIA (100.4 fever) and CHILLS (chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Myalgia, Pyrexia
Clinical narrative: he is complaining of lots of muscle pain/the muscle ache is moderate/muscle ache is still ongoing; he had high fevers as well/his fever was 103F; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (he is complaining of lots of muscle pain/the muscle ache is moderate/muscle ache is still ongoing) and PYREXIA (he had high fevers as well/his fever was 103F) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020 and Mechanical ventilation in 2020.    On 02-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Sep-2021, the patient experienced MYALGIA (he is complaining of lots of muscle pain/the muscle ache is moderate/muscle ache is still ongoing) and PYREXIA (he had high fevers as well/his fever was 103F). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Fever, at an unspecified dose and frequency and METHOCARBAMOL (ROBAXIN) for Adverse event, at an unspecified dose and frequency. On 03-Sep-2021, PYREXIA (he had high fevers as well/his fever was 103F) had resolved. At the time of the report, MYALGIA (he is complaining of lots of muscle pain/the muscle ache is moderate/muscle ache is still ongoing) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, Body temperature: 103 (High) 103  F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided by the reporter It was reported that the patient was a healthy person with no comorbidities and he exercise regularly He had infected with COVID 19 and nearly lost his life as he was on ventilator His wife reported that he had a natural immunity against the virus   Most recent FOLLOW-UP information incorporated above includes: On 09-Sep-2021: Follow-up contains lot number updated.
Sex: U
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Illness
Clinical narrative: Lot of people got sick; Experienced anxiety before the vaccine which is panic related due to covid; Lot of people felt tired/Fatigued; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Lot of people got sick), ANXIETY (Experienced anxiety before the vaccine which is panic related due to covid) and FATIGUE (Lot of people felt tired/Fatigued) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Lot of people got sick), ANXIETY (Experienced anxiety before the vaccine which is panic related due to covid) and FATIGUE (Lot of people felt tired/Fatigued). At the time of the report, ILLNESS (Lot of people got sick), ANXIETY (Experienced anxiety before the vaccine which is panic related due to covid) and FATIGUE (Lot of people felt tired/Fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patient received a vaccine that had Expiration date Mar 06, 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021). On 10-Mar-2021, EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.  On 10 March 2021 the vaccine was moved from freezer to refrigerator.   This case was linked to MOD-2021-307189 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Illness, Rash, Vaccination site swelling
Clinical narrative: Felt sick; Bad rash; Injection site got swollen; Numbness in right side of face; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt sick), HYPOAESTHESIA (Numbness in right side of face), RASH (Bad rash) and VACCINATION SITE SWELLING (Injection site got swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Felt sick), HYPOAESTHESIA (Numbness in right side of face), RASH (Bad rash) and VACCINATION SITE SWELLING (Injection site got swollen). At the time of the report, ILLNESS (Felt sick), RASH (Bad rash) and VACCINATION SITE SWELLING (Injection site got swollen) outcome was unknown and HYPOAESTHESIA (Numbness in right side of face) had resolved.            Concomitant medication details were not reported by the reporter. Treatment details included Benadryl after the first dose adverse event.   This case was linked to MOD-2021-314623 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Pallor
Clinical narrative: Im pale after receiving the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PALLOR (Im pale after receiving the vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced PALLOR (Im pale after receiving the vaccination). At the time of the report, PALLOR (Im pale after receiving the vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was provided.   Reporter did not allow further contact
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pain in extremity, Vaccination site pain
Clinical narrative: Arm pain; injection site pain; Arthralgias; Headache; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Arm pain), VACCINATION SITE PAIN (injection site pain), ARTHRALGIA (Arthralgias) and HEADACHE (Headache) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunosuppression.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2020, the patient experienced PAIN IN EXTREMITY (Arm pain), VACCINATION SITE PAIN (injection site pain), ARTHRALGIA (Arthralgias) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain), VACCINATION SITE PAIN (injection site pain), ARTHRALGIA (Arthralgias) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use included immunosuppressant medication.   This case was linked to MOD-2021-314740, MOD-2021-314741 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: two children less than 18 years old received the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (two children less than 18 years old received the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (two children less than 18 years old received the vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (two children less than 18 years old received the vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were provided. Clinical Pharmacist (caller) states he is not sure howold the children are, but they are just under the age of 18, he thinks they are 16 and 17 years of age were administered the moderna covid-19 vaccine instead of the Pfizer vaccine.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04721A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported No treatment Drug was reported
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient was administered a dose of the Moderna COVID from a pre drawn syringe stored at room temperature for 23 hours; ts that the third dose was given from a pre drawn syringe which had been stored at room temperature for longer than; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Patient was administered a dose of the Moderna COVID from a pre drawn syringe stored at room temperature for 23 hours) and EXPIRED PRODUCT ADMINISTERED (ts that the third dose was given from a pre drawn syringe which had been stored at room temperature for longer than) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient was administered a dose of the Moderna COVID from a pre drawn syringe stored at room temperature for 23 hours) and EXPIRED PRODUCT ADMINISTERED (ts that the third dose was given from a pre drawn syringe which had been stored at room temperature for longer than). At the time of the report, PRODUCT STORAGE ERROR (Patient was administered a dose of the Moderna COVID from a pre drawn syringe stored at room temperature for 23 hours) and EXPIRED PRODUCT ADMINISTERED (ts that the third dose was given from a pre drawn syringe which had been stored at room temperature for longer than) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications includes Acuvar Readihaler, Vitamin D, Multivitamin   Treatment medications was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patient received a vaccine that had Expiration date Mar 06, 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021). On 10-Mar-2021, EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drug was not reported. Treatment medication was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: given doses after 30 days/doses that were stored longer than 30 days were administered to 30-40 indivuduals; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given doses after 30 days/doses that were stored longer than 30 days were administered to 30-40 indivuduals) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (given doses after 30 days/doses that were stored longer than 30 days were administered to 30-40 indivuduals). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given doses after 30 days/doses that were stored longer than 30 days were administered to 30-40 indivuduals) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Moderna vaccines were stored under improper storage conditions due to loss of power for more than 30 days and were administered to 30-40 individuals and none of the vail had temperature excursion and all the doses administered were 1st, 2nd and 3rd doses and were administered through intramuscular. No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-Sep-2021: Follow-up received contains significant information updated list of patients who took expired vaccine and all details were provided.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patient received a vaccine that had Expiration date Mar 06, 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site pain, Pain in extremity, Pyrexia
Clinical narrative: Arm pain; Injection site pain; Arthralgias; Headache; All of that plus fever; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Arm pain), INJECTION SITE PAIN (Injection site pain), ARTHRALGIA (Arthralgias), HEADACHE (Headache) and PYREXIA (All of that plus fever) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2020, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain), INJECTION SITE PAIN (Injection site pain), ARTHRALGIA (Arthralgias), HEADACHE (Headache) and PYREXIA (All of that plus fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain), INJECTION SITE PAIN (Injection site pain), ARTHRALGIA (Arthralgias), HEADACHE (Headache) and PYREXIA (All of that plus fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication was reported.   This case was linked to MOD-2021-314678, MOD-2021-314741 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: Administered a 1 mL dose instead of 0.5 mL; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (Administered a 1 mL dose instead of 0.5 mL) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 09-Sep-2021, the patient experienced ACCIDENTAL OVERDOSE (Administered a 1 mL dose instead of 0.5 mL). On 09-Sep-2021, ACCIDENTAL OVERDOSE (Administered a 1 mL dose instead of 0.5 mL) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was provided by the reporter.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: A 15 and ½ year old received the vaccine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Sep-2021 and was forwarded to Moderna on 09-Sep-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 15 and ½ year old received the vaccine) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 15 and ½ year old received the vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 15 and ½ year old received the vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lethargy, Pyrexia, Rash, Rash erythematous
Clinical narrative: 50 cent sized red raised skin; rash; fever; chills; lethargic; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Sep-2021 and was forwarded to Moderna on 09-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (50 cent sized red raised skin), RASH (rash), PYREXIA (fever), CHILLS (chills) and LETHARGY (lethargic) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (50 cent sized red raised skin), RASH (rash), PYREXIA (fever), CHILLS (chills) and LETHARGY (lethargic). At the time of the report, RASH ERYTHEMATOUS (50 cent sized red raised skin), RASH (rash), PYREXIA (fever), CHILLS (chills) and LETHARGY (lethargic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported No treatment drug was reported
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pyrexia (temp currently 103.3ºF/102.3ºF) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pyrexia (temp currently 103.3ºF/102.3ºF). At the time of the report, pyrexia (temp currently 103.3ºF/102.3ºF): not resolved. Diagnostic results: On an unknown date, body temperature: 103.3ºF (high) 103.3 and 102.3ºF (high). The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant production use and treatment information not reported.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: My spouse received the Pfizer vaccine on the first dose and the second Moderna is there any reason for concern?; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (My spouse received the Pfizer vaccine on the first dose and the second Moderna is there any reason for concern?) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Previously administered products included for an unreported indication: PFIZER BIONTECH COVID-19 VACCINE.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (My spouse received the Pfizer vaccine on the first dose and the second Moderna is there any reason for concern?). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (My spouse received the Pfizer vaccine on the first dose and the second Moderna is there any reason for concern?) had resolved.            No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered with expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032N20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 08-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.   This case was linked to MOD-2021-314567, MOD-2021-314570, MOD-2021-314573, MOD-2021-314793, MOD-2021-314545, MOD-2021-314555, MOD-2021-314805, MOD-2021-314810, MOD-2021-314805 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2021: Follow-up information included no new information
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered with expired vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032N20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 08-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine). On 08-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-314570, MOD-2021-314573, MOD-2021-314805, MOD-2021-314545, MOD-2021-314555, MOD-2021-314567, MOD-2021-314810, MOD-2021-314810 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2021: Follow-up information included no new information
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Gait disturbance, Pain, Pyrexia
Clinical narrative: Feels like he got dragged; Vomiting; Fever of 101.5 degrees F; Aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Feels like he got dragged), VOMITING (Vomiting), PYREXIA (Fever of 101.5 degrees F), PAIN (Aches) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (Feels like he got dragged), VOMITING (Vomiting), PYREXIA (Fever of 101.5 degrees F), PAIN (Aches) and CHILLS (Chills). At the time of the report, GAIT DISTURBANCE (Feels like he got dragged), VOMITING (Vomiting), PYREXIA (Fever of 101.5 degrees F), PAIN (Aches) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, Body temperature: 101.5 (High) Fever of 101.5 degrees F.         No concomitant medications were mentioned. No treatment details were reported.